Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6655049rdf:typepubmed:Citationlld:pubmed
pubmed-article:6655049lifeskim:mentionsumls-concept:C0007806lld:lifeskim
pubmed-article:6655049lifeskim:mentionsumls-concept:C0026473lld:lifeskim
pubmed-article:6655049lifeskim:mentionsumls-concept:C0014072lld:lifeskim
pubmed-article:6655049lifeskim:mentionsumls-concept:C0035020lld:lifeskim
pubmed-article:6655049lifeskim:mentionsumls-concept:C1521761lld:lifeskim
pubmed-article:6655049lifeskim:mentionsumls-concept:C0205191lld:lifeskim
pubmed-article:6655049pubmed:issue3lld:pubmed
pubmed-article:6655049pubmed:dateCreated1984-2-23lld:pubmed
pubmed-article:6655049pubmed:abstractTextCerebrospinal fluid (CSF) was removed from guinea pigs with chronic relapsing experimental allergic encephalomyelitis (CR-EAE) and control inoculated animals by puncture of the cisterna magna. The fluid from 7/8 animals in relapse and 2/4 animals in remission phases of CR-EAE was found to promote the migration of peripheral blood monocytes through a 5-micron pore diameter polycarbonate membrane filter. Monocytes were also found to orient towards the migration-stimulating CSF in a gradient formed between such fluid and CSF derived from a control animal, thereby indicating the presence of a chemotactic factor. The factor responsible for promoting monocyte migration had a molecular weight of between 50 000 and 300 000 as defined by ultrafiltration. The results are discussed in relation to the known pathohistological features of the chronic relapsing disease.lld:pubmed
pubmed-article:6655049pubmed:languageenglld:pubmed
pubmed-article:6655049pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6655049pubmed:citationSubsetIMlld:pubmed
pubmed-article:6655049pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6655049pubmed:statusMEDLINElld:pubmed
pubmed-article:6655049pubmed:monthDeclld:pubmed
pubmed-article:6655049pubmed:issn0165-5728lld:pubmed
pubmed-article:6655049pubmed:authorpubmed-author:RumsbyM GMGlld:pubmed
pubmed-article:6655049pubmed:authorpubmed-author:SucklingA JAJlld:pubmed
pubmed-article:6655049pubmed:authorpubmed-author:KirbyJ AJAlld:pubmed
pubmed-article:6655049pubmed:issnTypePrintlld:pubmed
pubmed-article:6655049pubmed:volume5lld:pubmed
pubmed-article:6655049pubmed:ownerNLMlld:pubmed
pubmed-article:6655049pubmed:authorsCompleteYlld:pubmed
pubmed-article:6655049pubmed:pagination271-81lld:pubmed
pubmed-article:6655049pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:6655049pubmed:meshHeadingpubmed-meshheading:6655049-...lld:pubmed
pubmed-article:6655049pubmed:meshHeadingpubmed-meshheading:6655049-...lld:pubmed
pubmed-article:6655049pubmed:meshHeadingpubmed-meshheading:6655049-...lld:pubmed
pubmed-article:6655049pubmed:meshHeadingpubmed-meshheading:6655049-...lld:pubmed
pubmed-article:6655049pubmed:meshHeadingpubmed-meshheading:6655049-...lld:pubmed
pubmed-article:6655049pubmed:meshHeadingpubmed-meshheading:6655049-...lld:pubmed
pubmed-article:6655049pubmed:meshHeadingpubmed-meshheading:6655049-...lld:pubmed
pubmed-article:6655049pubmed:year1983lld:pubmed
pubmed-article:6655049pubmed:articleTitleChronic relapsing experimental allergic encephalomyelitis. The presence in the cerebrospinal fluid of factors chemotactic for monocytes.lld:pubmed
pubmed-article:6655049pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6655049pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6655049lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6655049lld:pubmed